Pulmonary disease, chronic obstructive Trials in Durban, South Africa
Conditions / Pulmonary disease, chronic obstructive / Durban, South Africa
Research into Pulmonary disease, chronic obstructive spans multiple therapeutic approaches and trial phases.
23 total trials for this combination
Showing top 10 of 23 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT01313650 | A 24-week Evaluation of GSK573719/Vilanterol (62.5/25mcg) and Components in COPD | COMPLETED | PHASE3 |
| NCT01009463 | A Study to Evaluate the Efficacy and Safety of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE3 |
| NCT01126437 | Comparison of Tiotropium in the HandiHaler Versus the Respimat in Chronic Obstructive Pulmonary Disease | COMPLETED | PHASE3 |
| NCT00268216 | Survival Of Subjects With Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE3 |
| NCT00144339 | Evaluation of the Long- Term Effects of Spiriva on Lung Function in COPD Patients | COMPLETED | PHASE3 |
| NCT02164513 | A Study Comparing the Efficacy, Safety and Tolerability of Fixed Dose Combination (FDC) of FF/UMEC/VI With the FDC of FF/VI and UMEC/VI; Administered Once-daily Via a Dry Powder Inhaler (DPI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE3 |
| NCT00152984 | Efficacy and Safety of Tiotropium in Patients With COPD and Concomitant Diagnosis of Asthma | COMPLETED | PHASE4 |
| NCT01543919 | Study To Evaluate The Efficacy And Safety Of PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide | COMPLETED | PHASE2 |
| NCT00387088 | Tiotropium / Respimat One Year Study in COPD. | COMPLETED | PHASE3 |
| NCT01313676 | Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease | COMPLETED | PHASE3 |